Drug Profile
Research programme: prostaglandin EP4 receptor agonists - GlaxoSmithKline
Alternative Names: GSK 324202ALatest Information Update: 18 Apr 2011
Price :
$50
*
At a glance
- Originator GlaxoSmithKline
- Class
- Mechanism of Action Dinoprostone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 07 Nov 2006 Preclinical trials in Pain in United Kingdom (unspecified route)